Pharscin Pharma(SZ:002907) Shang Hai Zheng Quan Bao·2025-07-30 19:15Core Viewpoint - The announcement details the completion of the share reduction plan by the controlling shareholder and senior management of Chongqing Huason Pharmaceutical Co., Ltd, confirming that the information provided is accurate and complete [1][2]. Shareholder Reduction Situation - Chengdu Local Construction Machinery Engineering Co., Ltd (the controlling shareholder) planned to reduce its shares by a total of up to 12,527,889 shares, which is 3% of the company's total share capital, through both centralized bidding and block trading from June 6 to September 5, 2025 [2]. - Senior management member Peng Xiaoyan planned to reduce her shares by up to 4,375 shares, which is 0.0010% of the company's total share capital, during the same period [2]. Implementation of Reduction Plan - As of the announcement date, both Chengdu Local Construction and Peng Xiaoyan have completed their share reduction plans as previously disclosed [4][5]. - The share reduction was conducted in compliance with relevant laws and regulations, ensuring no violation of share lock-up commitments or short-term trading rules [7]. Shareholding Situation Post-Reduction - The announcement includes details on the shareholding status of Chengdu Local Construction and its concerted actions before and after the reduction [4][6]. - The reduction plan's implementation will not lead to any change in the company's control or affect its ongoing operations [7].